Latest Breaking News On - Duncan peyton - Page 13 : comparemela.com

4D pharma plc: 4D Pharma to Participate in Upcoming Cantor Fitzgerald Microbiome Leaders Panel 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) a novel class of drug derived from the microbiome, today announces Duncan Peyton, Chief Executive Officer of 4D pharma, will participate in Cantor Fitzgerald s virtual panel, titled Microbiome Players with Guided Readouts in 2021, on Thursday, February 18, 2021 at 15:00 GMT (10:00 ET). A webcast of the panel will be available via the Events section of the 4D pharma website at www.4dpharmaplc.com. About 4D pharma Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationall

United statesJulie seidelDominic wilson phil walkerNeil hunter michelle boxallDuncan peytonBryan garnier coStern investor relations incImage box communicationsExchange commissionMerck co incUnited states securities exchangeCantor fitzgeraldChief executive officerGuided readoutsIrritable bowel syndromeUnited states securities act